foxo4 dri senolytic peptide study The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Specification:20 mg Unscented TB-500 Capsules vs. Injectable
SKU: 12902940803
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
























